Meditorin Tablet 10/20 Milligrams
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Medix Pharmaceuticals Co., Ltd.
MFDS item code 201901089 · Approved 2019.02.22
This product's status changed to Expired on 2024.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
This medication helps to control cholesterol and lipid levels in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial hypercholesterolemia, as well as mixed hyperlipidemia. It lowers total cholesterol, LDL-cholesterol, apolipoprotein B, and triglyceride levels while increasing levels of HDL-cholesterol, serving as a complement to dietary measures. Additionally, it can be used in patients with homozygous familial hypercholesterolemia when other treatments are ineffective or as adjunct therapy. This drug should be used alongside dietary restrictions such as limiting saturated fat and cholesterol intake, and it is crucial to verify any secondary causes such as diseases or medications before administration. In patients with acute coronary events, treatment may begin based on lipid levels. In summary, this drug effectively improves hypercholesterolemia, which may lead to increased cardiovascular risk.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who need less LDL cholesterol reduction may start at 10/10mg daily. After starting this medicine or adjusting the dose, check blood lipid levels after an interval of 4 weeks or more and then adjust the dose. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment, but this medicine is not recommended in patients with moderate or severe hepatic impairment (see the section on patients with impaired liver function under 4. General Precautions in Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine cautiously in these patients and monitor them closely (see 4. General Precautions under Precautions for Use). Administration in older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 5. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication can cause serious side effects such as myopathy and rhabdomyolysis, thus any symptoms of muscle pain or weakness should be reported to a physician immediately. This medication should not be used in specific patients, such as those allergic to its ingredients, those with active liver disease, pregnant or breastfeeding women, and patients on certain medications. As it can affect liver function, caution is required in patients with a history of liver disease or suspected liver dysfunction, and periodic liver function tests may be necessary. It may interact with multiple drugs, so patients taking other medications should inform their doctor or pharmacist, particularly avoiding co-administration with strong CYP3A4 inhibitors or certain fibrate medications. Pregnant women or those planning to become pregnant should not take this medication and should discontinue it immediately if pregnancy is confirmed. Breastfeeding women should not take this medication and should cease breastfeeding if it is taken. Elderly patients or those with impaired kidney function may be more sensitive to the drug's side effects and should exercise extra caution. During treatment, side effects such as muscle pain, fatigue, dyspepsia, headache, etc., may occur, and any unusual symptoms should be discussed with healthcare personnel immediately. In cases of overdose, there is no specific antidote, and symptomatic treatment will be provided as needed. Prolonged use of this medication may lead to rare pulmonary side effects such as interstitial lung disease, so if symptoms like shortness of breath or persistent cough occur, consultation with a physician is necessary. It is important to regularly monitor muscle and liver function tests when starting or adjusting this medication's dosage. This medication may increase the risk of diabetes, so patients needing blood sugar control should monitor their blood sugar levels regularly.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture; therefore, it should be stored in a tightly closed container. It is advisable to maintain room temperature between 1 and 30 degrees Celsius.
A white to off-white, bilaterally convex, rectangular tablet.
30 tablets - 10 tablets/Blister, 30 tablets - 3 Blisters/Box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Medix Pharmaceuticals Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.